Home › Funds › Northern Trust Corp › REGN
Northern Trust Corp position in REGN
REGENERON PHARMACEUTICALS INC. · Health Care
Latest position (Q2 2026)916.47K sh
Reported value held$571.45M
Portfolio Weight0.07%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 1.20M | $726.24M | New |
| Q4 2021 | 1.20M | $759.92M | Hold |
| Q1 2022 | 1.20M | $838.88M | Hold |
| Q2 2022 | 1.20M | $708.86M | Hold |
| Q3 2022 | 1.19M | $818.93M | Reduce |
| Q4 2022 | 1.16M | $839.82M | Reduce |
| Q1 2023 | 1.15M | $948.68M | Reduce |
| Q2 2023 | 1.03M | $742.17M | Reduce |
| Q3 2023 | 1.07M | $878.27M | Add |
| Q4 2023 | 1.05M | $919.05M | Reduce |
| Q1 2024 | 991.47K | $954.28M | Reduce |
| Q2 2024 | 966.73K | $1.02B | Reduce |
| Q3 2024 | 918.64K | $965.72M | Reduce |
| Q4 2024 | 1.05M | $751.39M | Add |
| Q1 2025 | 1.00M | $635.34M | Reduce |
| Q2 2025 | 958.57K | $503.25M | Reduce |
| Q3 2025 | 984.79K | $553.72M | Add |
| Q4 2025 | 944.93K | $729.37M | Reduce |
| Q1 2026 | 941.94K | $727.78M | Hold |
| Q2 2026 | 916.47K | $571.45M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding REGN
- Vanguard Group 9.08M sh · $7.00B · Q4 2025
- BlackRock Inc 9.11M sh · $5.68B · Q2 2026
- Dodge & Cox 4.87M sh · $3.04B · Q2 2026
- Invesco Ltd 3.94M sh · $2.46B · Q2 2026
- JPMorgan Chase & Co 3.77M sh · $2.38B · Q2 2026
- Franklin Resources 2.77M sh · $1.73B · Q2 2026
- Geode Capital Management 2.63M sh · $1.63B · Q2 2026
- Morgan Stanley 1.40M sh · $871.53M · Q2 2026
- Goldman Sachs Group 1.33M sh · $831.98M · Q2 2026
- Bank of America Corp 1.29M sh · $805.02M · Q2 2026
- Wellington Management Group 1.27M sh · $791.95M · Q2 2026
- Norges Bank Investment Management 1.17M sh · $731.29M · Q2 2026